RECRUITING

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

Official Title

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

Quick Facts

Study Start:2020-05-01
Study Completion:2031-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05628974

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults aged 18 to 65 years old
  2. * Healthy Male \& Female voluntary participants
  1. * Individuals who have taken anticoagulant or antiplatelet medications in past 10 days
  2. * Individuals with hematopoetic diseases

Contacts and Locations

Study Contact

Scott Cameron, MD, PhD
CONTACT
216-444-1680
cameros3@ccf.org

Principal Investigator

Scott Cameron, MD, PhD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic

Study Locations (Sites)

Cleveland Clinic
Cleveland, Ohio, 44195
United States

Collaborators and Investigators

Sponsor: The Cleveland Clinic

  • Scott Cameron, MD, PhD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-05-01
Study Completion Date2031-06-30

Study Record Updates

Study Start Date2020-05-01
Study Completion Date2031-06-30

Terms related to this study

Additional Relevant MeSH Terms

  • Healthy